Relay Therapeutics, Inc. RLAY Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3M-60.9% | $7M— | $0— | $677K— | $7.68M-23.3% | ||
| $70.56M-4.4% | $55.42M-18.6% | $68.26M-10.9% | $63.9M-30.5% | $73.81M-10.4% | ||
| $11.03M-41.2% | $12.22M-27.7% | $12.13M-38.6% | $13.63M-32.3% | $18.74M-5.4% | ||
| $81.59M-11.8% | $67.63M-20.4% | $80.39M-16.6% | $77.52M-23.1% | $92.55M-7.8% | ||
| -$78.59M+7.4% | -$60.63M+28.7% | -$80.39M+16.6% | -$76.85M+23.7% | -$84.87M+6.1% | ||
| -2,619.7%-1,514pp | -866.1%— | —— | -11,351.1%— | -1,105.2%-202pp | ||
| $5.3M-32.1% | $5.74M-36.0% | $6.24M-24.5% | $6.47M-24.3% | $7.8M-13.1% | ||
| -$73.29M+4.9% | -$54.89M+27.8% | -$74.15M+15.8% | -$70.38M+23.7% | -$77.07M+5.3% | ||
| -2,443%-1,439pp | -784.1%— | —— | -10,395.1%— | -1,003.6%-190pp | ||
| -$0.41+10.9% | -$0.31+26.2% | -$0.43+31.7% | -$0.41+40.6% | -$0.46+25.8% | ||
| -$78.09M+6.7% | -$60.03M+28.2% | -$79.64M+16.2% | -$75.85M+23.7% | -$83.66M+6.0% | ||
| -2,602.9%-1,513pp | -857.6%— | —— | -11,203.1%— | -1,089.5%-200pp | ||
| -$78.59M+7.4% | -$60.63M+28.7% | -$80.39M+16.6% | -$76.85M+23.7% | -$84.87M+6.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Relay Therapeutics, Inc.'s revenue?
- Relay Therapeutics, Inc. (RLAY) generated $10.7M in revenue over the trailing twelve months, up 39.0% year over year.
- Is Relay Therapeutics, Inc. profitable?
- Relay Therapeutics, Inc. is not currently profitable: it reported a net loss of $272.7M over the trailing twelve months, a -2554.1% net margin.
- What is Relay Therapeutics, Inc.'s earnings per share?
- Relay Therapeutics, Inc.'s diluted EPS over the trailing twelve months is $-1.56.
- Where does Relay Therapeutics, Inc.'s income statement data come from?
- Every line is extracted from Relay Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
